Lineage Cell Therapeutics In shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $305k | 206k | 1.48 |
| 2023-12-31 | $177k | 163k | 1.09 |
| 2023-09-30 | $215k | 183k | 1.18 |
| 2023-06-30 | $357k | 253k | 1.41 |
| 2023-03-31 | $362k | 241k | 1.50 |
| 2022-12-31 | $306k | 262k | 1.17 |
| 2022-09-30 | $326k | 288k | 1.13 |
| 2022-06-30 | $214k | 135k | 1.58 |
| 2022-03-31 | $18k | 12k | 1.50 |
| 2020-09-30 | $14k | 15k | 0.96 |
| 2020-06-30 | $49k | 57k | 0.87 |
| 2020-03-31 | $42k | 51k | 0.83 |
| 2019-12-31 | $20k | 22k | 0.90 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management